SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-200265"
 

Search: onr:"swepub:oai:DiVA.org:liu-200265" > Prevention, Diagnos...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Awan, Ahmed Arslan YousufBaylor Coll Med, TX USA (author)

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • AMER COLL PHYSICIANS,2023
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-200265
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-200265URI
  • https://doi.org/10.7326/M23-2391DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:154624409URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|KDIGO
  • Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 clinical practice guideline on prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease (CKD) is an update of the 2018 guideline from KDIGO.Methods: The KDIGO Work Group (WG) updated the guideline, which included reviewing and grading new evidence that was identified and summarized. As in the previous guideline, the WG used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to appraise evidence and rate the strength of recommendations and used expert judgment to develop recommendations. New evidence led to updating of recommendations in the chapters on treatment of hepatitis C virus (HCV) infection in patients with CKD (Chapter 2), management of HCV infection before and after kidney transplant (Chapter 4), and diagnosis and management of kidney disease associated with HCV infection (Chapter 5). Recommendations in chapters on detection and evaluation of hepatitis C in CKD (Chapter 1) and prevention of HCV transmission in hemodialysis units (Chapter 3) were not updated because of an absence of significant new evidence.Recommendations: The 2022 updated guideline includes 43 graded recommendations and 20 ungraded recommendations, 7 of which are new or modified on the basis of the most recent evidence and consensus among the WG members. The updated guidelines recommend expanding treatment of hepatitis C with sofosbuvir-based regimens to patients with CKD glomerular filtration rate categories G4 and G5, including those receiving dialysis; expanding the donor pool for kidney transplant recipients by accepting HCV-positive kidneys regardless of the recipient's HCV status; and initiating direct-acting antiviral treatment of HCV-infected patients with clinical evidence of glomerulonephritis without requiring kidney biopsy. The update also addresses the use of immunosuppressive regimens in such patients.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Berenguer, Marina C.Univ Valencia, Spain; Univ Valencia, Spain; Ctr Invest Biomed Red Enfermedades Hepat & Digest, Spain; Univ Valencia, Spain (author)
  • Bruchfeld, AnnetteLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Univ Hosp, Sweden; CLINTEC Karolinska Inst, Sweden(Swepub:liu)anbru14 (author)
  • Fabrizi, FabrizioMaggiore Policlin Hosp, Italy; IRCCS Ca Granda Fdn, Italy (author)
  • Goldberg, David S.Univ Miami, FL USA (author)
  • Jia, JidongCapital Med Univ, Peoples R China; Beijing Key Lab Transit Med Liver Cirrhosis, Peoples R China; Natl Clin Res Ctr Digest Dis, Peoples R China (author)
  • Kamar, NassimUniv Paul Sabatier, France; Univ Paul Sabatier, France (author)
  • Mohamed, RosmawatiUniv Malaya, Malaysia (author)
  • Pessoa, Mario GuimaraesUniv Sao Paulo, Brazil (author)
  • Pol, StanislasParis Descartes Univ, France (author)
  • Sise, Meghan E.Massachusetts Gen Hosp, MA 02114 USA (author)
  • Balk, Ethan M.Brown Univ, RI 02912 USA (author)
  • Gordon, Craig E.Tufts Med Ctr, MA 02111 USA (author)
  • Adam, GaelenBrown Univ, RI 02912 USA (author)
  • Cheung, MichaelKDIGO, Belgium (author)
  • Earley, AmyKDIGO, Belgium (author)
  • Martin, PaulUniv Miami, FL USA (author)
  • Jadoul, MichelCatholic Univ Louvain, Belgium (author)
  • Baylor Coll Med, TX USAUniv Valencia, Spain; Univ Valencia, Spain; Ctr Invest Biomed Red Enfermedades Hepat & Digest, Spain; Univ Valencia, Spain (creator_code:org_t)

Related titles

  • In:Annals of Internal Medicine: AMER COLL PHYSICIANS176, s. 1648-16550003-48191539-3704

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view